Biofrontera (BFRIW) Operating Income (2020 - 2025)
Historic Operating Income for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to -$6.3 million.
- Biofrontera's Operating Income fell 2657.26% to -$6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year increase of 902.24%. This contributed to the annual value of -$17.2 million for FY2024, which is 2410.81% up from last year.
- As of Q3 2025, Biofrontera's Operating Income stood at -$6.3 million, which was down 2657.26% from -$5.1 million recorded in Q2 2025.
- Biofrontera's 5-year Operating Income high stood at -$1.7 million for Q4 2024, and its period low was -$16.1 million during Q3 2021.
- Its 5-year average for Operating Income is -$5.2 million, with a median of -$5.0 million in 2024.
- As far as peak fluctuations go, Biofrontera's Operating Income crashed by 58707.34% in 2021, and later soared by 7740.45% in 2022.
- Quarter analysis of 5 years shows Biofrontera's Operating Income stood at -$1.9 million in 2021, then tumbled by 196.86% to -$5.6 million in 2022, then soared by 30.75% to -$3.9 million in 2023, then surged by 55.71% to -$1.7 million in 2024, then crashed by 266.71% to -$6.3 million in 2025.
- Its Operating Income stands at -$6.3 million for Q3 2025, versus -$5.1 million for Q2 2025 and -$4.5 million for Q1 2025.